Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke

AIM: The effectiveness of neuroprotective agents is still unclear. Here we analyzed the clinical outcomes of acute ischemic stroke (AIS) patients treated with human urinary kallidinogenase (HUK) or edaravone (Eda) combined with butylphthalide (NBP). METHODS: From January 2016 to December 2017, a tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Yun, Lyu, Yi, Jiang, Minhai, Tang, Bo, Nie, Tian, Lu, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908872/
https://www.ncbi.nlm.nih.gov/pubmed/31638334
http://dx.doi.org/10.1002/brb3.1438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908872/
https://www.ncbi.nlm.nih.gov/pubmed/31638334
http://dx.doi.org/10.1002/brb3.1438

Ejemplares similares